Department of Immunology and Inflammation, Imperial College London, Du Cane Road W12 0NN, London, UK.
Int J Biol Sci. 2021 Jul 5;17(11):2770-2771. doi: 10.7150/ijbs.63969. eCollection 2021.
Commentary on 'Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19' by Sun et al.
评孙等人的“Capivasertib 限制 SARS-CoV-2 细胞进入:COVID-19 的一种潜在临床应用”一文